Your browser doesn't support javascript.
loading
Overexpression of transcription factor TBX5 inhibits the activation of YAP1-TEAD1 pathway to promote ferroptosis in lung cancer cells.
Ma, Ruoting; Hu, Ke; Dai, Siyuan; Wang, Yiqun.
Afiliación
  • Ma R; General Medicine Department, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, PR China. Electronic address: maruoting@csu.edu.cn.
  • Hu K; Medical College, Hunan University of Medicine, Huaihua, 418000, Hunan, PR China.
  • Dai S; Geriatric Medicine Department, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, PR China.
  • Wang Y; Geriatric Medicine Department, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, PR China.
Biochem Biophys Res Commun ; 718: 150037, 2024 07 23.
Article en En | MEDLINE | ID: mdl-38735135
ABSTRACT

BACKGROUND:

Non-small cell lung cancer (NSCLC) accounts for more than 80 % of lung cancer (LC) cases, making it the primary cause of cancer-related mortality worldwide. T-box transcription factor 5 (TBX5) is an important regulator of embryonic and organ development and plays a key role in cancer development. Here, our objective was to investigate the involvement of TBX5 in ferroptosis within LC cells and the underlying mechanisms.

METHODS:

First, TBX5 expression was examined in human LC cells. Next, overexpression of TBX5 and Yes1-associated transcriptional regulator (YAP1) and knockdown of TEA domain 1 (TEAD1) were performed in A549 and NCI-H1703 cells. The proliferation ability of A549 and NCI-H1703 cells, GSH, MDA, ROS, and Fe2+ levels were measured. Co-immunoprecipitation (Co-IP) was performed to verify whether TBX5 protein could bind YAP1. Then TBX5, YAP1, TEAD1, GPX4, p53, FTH1, SLC7A11 and PTGS2 protein levels were assessed. Finally, we verified the effect of TBX5 on ferroptosis in LC cells in vivo.

RESULTS:

TBX5 expression was down-regulated in LC cells, especially in A549 and NCI-H1703 cells. Overexpression of TBX5 significantly decreased proliferation ability of A549 and NCI-H1703 cells, downregulated GPX4 and GSH levels, and upregulated MDA, ROS, and Fe2+ levels. Co-IP verified that TBX5 protein could bind YAP1. Moreover, oe-YAP1 promoted proliferation ability of A549 and NCI-H1703 cells transfected with Lv-TBX5, upregulated GPX4 and GSH levels and downregulated MDA, ROS, and Fe2+ levels. Additionally, oe-YAP1 promoted FTH1 and SLC7A11 levels and inhibited p53 and PTGS2 levels in A549 and NCI-H1703 cells transfected with Lv-TBX5. However, transfection with si-TEAD1 further reversed these effects. In vivo experiments further validated that TBX5 promoted ferroptosis in LC cells.

CONCLUSIONS:

TBX5 inhibited the activation of YAP1-TEAD1 pathway to promote ferroptosis in LC cells.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas de Dominio T Box / Ferroptosis / Proteínas Señalizadoras YAP / Factores de Transcripción de Dominio TEA / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas de Dominio T Box / Ferroptosis / Proteínas Señalizadoras YAP / Factores de Transcripción de Dominio TEA / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos